- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07778186
AI-driven Multiple Interactive Teaching Model on Nuclear Medicine Students' Theoretical Knowledge and Practical Skills
August 20, 2026 updated by: Hao Wang, Sichuan Provincial People's Hospital
The Impact of AI-driven Multiple Interactive Teaching Model on Nuclear Medicine Students' Theoretical Knowledge and Practical Skills
This single-center randomized controlled trial will enroll 85 nuclear medicine undergraduate students.
Participants will be randomized into two arms: a three-stage AI multi-interactive teaching intervention group (n=43) and a conventional lecture-based control group (n=42).
The study is designed to compare theoretical knowledge, instructor-rated performance, student satisfaction, discussion participation, core concept comprehension, and classroom engagement between the two teaching approaches.
Planned evaluations will be conducted after the teaching intervention.
Study Overview
Status
Completed
Study Type
Interventional
Enrollment (Actual)
85
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Sichuan
-
Chengdu, Sichuan, China, 610072
- Hao Wang
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Undergraduate students majoring in clinical medicine who take the nuclear medicine theoretical course.
- Age ≥18 years old.
- Voluntarily agree to participate in this study and provide informed consent.
- Complete the full-cycle nuclear medicine teaching activities.
Exclusion Criteria:
- Students who have previously received systematic nuclear medicine coursework.
- Incomplete participation in teaching activities or missing post-intervention assessment data.
- Students who refuse to join this research.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: AI-driven multiple interactive teaching group
|
Undergraduate students receive nuclear medicine theoretical courses via AI-driven multiple interactive teaching mode.
|
|
Active Comparator: Traditional lecture-based teaching group
|
Undergraduate students receive standard nuclear medicine theoretical courses by conventional lecture-based teaching.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Difference in post-test theoretical knowledge scores of nuclear medicine between the two student groups
Time Frame: At the end of the teaching intervention (approximately 4-week teaching period)
|
Nuclear medicine theoretical knowledge post-test score; examination scale range from 0 (minimum, poorest performance) to 100 (maximum, best performance).
Higher scores indicate better theoretical knowledge mastery.
The between-group score difference will be compared.
|
At the end of the teaching intervention (approximately 4-week teaching period)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Difference in student classroom engagement scores between AI-driven teaching group and traditional lecture group
Time Frame: At the end of the teaching intervention (approximately 4-week teaching period)
|
Student classroom engagement is assessed using a validated classroom engagement rating scale.
The total scale score ranges from 20 (minimum, poorest classroom engagement) to 100 (maximum, optimal classroom engagement).
Higher scores represent better classroom engagement of students.
The difference in post-intervention engagement scores between the two groups will be analyzed.
|
At the end of the teaching intervention (approximately 4-week teaching period)
|
|
Difference in learning satisfaction questionnaire scores between the two groups
Time Frame: At the end of the teaching intervention (approximately 4-week teaching period)
|
Student learning satisfaction is evaluated with a standardized learning satisfaction questionnaire.
The overall questionnaire score ranges from 10 (minimum, lowest learning satisfaction) to 50 (maximum, highest learning satisfaction).
Higher scores indicate higher student learning satisfaction with nuclear medicine teaching.
Post-intervention satisfaction scores are compared between the AI-driven teaching group and the traditional lecture group.
|
At the end of the teaching intervention (approximately 4-week teaching period)
|
|
Difference in practical-relevant learning experience scores between the two groups
Time Frame: At the end of the teaching intervention (approximately 4-week teaching period)
|
Students' practical-relevant learning experience is assessed using a validated practical learning experience scale.
The total scale score ranges from 15 (minimum, poorest practical learning experience) to 75 (maximum, optimal practical learning experience).
Higher scores represent better practical learning experience and stronger perceived mastery of nuclear medicine practical knowledge.
Post-intervention learning experience scores are compared between the AI-driven teaching group and the traditional lecture group.
|
At the end of the teaching intervention (approximately 4-week teaching period)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 1, 2025
Primary Completion (Actual)
June 30, 2025
Study Completion (Actual)
June 30, 2025
Study Registration Dates
First Submitted
August 17, 2026
First Submitted That Met QC Criteria
August 20, 2026
First Posted (Actual)
August 21, 2026
Study Record Updates
Last Update Posted (Actual)
August 21, 2026
Last Update Submitted That Met QC Criteria
August 20, 2026
Last Verified
August 1, 2026
More Information
Terms related to this study
Other Study ID Numbers
- SichuanPPH-teaching
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.